SensiGene™ Fetal RHD Genotyping test

	Next higher product group	prenatal genetic test
	Status	2007-12-27 registration start
	Organisation	Sequenom (Group)
	Indication

Record changed: 2011-11-25

More documents for prenatal genetic test

[1] Sequenom, Inc.. (3/15/10). "Press Release: Sequenom Reports 2009 Fourth Quarter and Full Year Financial Results. Full Year 2009 Revenues of $37.9 Million with Year End Cash and Equivalents of $42.7 Million". San Diego, CA....
[2] Sequenom, Inc.. (2/16/10). "Press Release: Sequenom Announces Launch of SensiGene Fetal(XY) (Fetal Sex Determination)". San Diego, CA....
[3] Sequenom, Inc.. (2/4/10). "Press Release: Sequenom Announces Launch of SensiGene Fetal RHD genotyping Test. First Commercial Test Using SEQureDx Technology for Determining Rhesus D Incompatibility". San Diego, CA....
[4] Sequenom, Inc.. (9/28/09). "Press Release: Sequenom Announces Completion of Independent Investigation". San Diego, CA....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

Follow Us!

Top News

Upcoming Events

Associations

Partners

SensiGene™ Fetal RHD Genotyping test

More documents for prenatal genetic test